Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
1,111.80
-2.00 (-0.18%)
Jul 24, 2026, 3:30 PM IST
Zydus Lifesciences Employees
Zydus Lifesciences had 29,980 employees as of March 31, 2026. The number of employees increased by 2,063 or 7.39% compared to the previous year.
Employees
29,980
Change (1Y)
2,063
Growth (1Y)
7.39%
Revenue / Employee
9.06M INR
Profits / Employee
1.68M INR
Market Cap
1.11T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 29,980 | 2,063 | 7.39% |
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Dec 31, 2022 | 23,000 | -743 | -3.13% |
| Sep 30, 2022 | 23,000 | - | - |
| Jun 30, 2022 | 23,000 | -1,412 | -5.78% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 31,369 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 20,451 |
| Alkem Laboratories | 18,785 |
| Ipca Laboratories | 17,210 |
| Glenmark Pharmaceuticals | 15,800 |
| Divi's Laboratories | 11,565 |
| Ajanta Pharma | 9,628 |
Zydus Lifesciences News
- 2 days ago - Zydus gets approval for Phase III trial of sickle cell disease drug - The Times of India
- 26 days ago - Zydus Lifesciences extends API business acquisition deadline to September 2026 - Business Upturn
- 4 weeks ago - Zydus Lifesciences invests USD 5 million in joint venture with Sunshine Healthcare - Business Upturn
- 5 weeks ago - Zydus Lifesciences sees significant buyback participation from promoters - Business Upturn
- 5 weeks ago - Zydus Lifesciences completes Rs 1,100 crore buyback extinguishing over 87 lakh shares - Business Upturn
- 5 weeks ago - Top stocks for trade today, June 17: Infosys, Wipro, TCS, Zydus Lifesciences, Bharat Forge and more - Business Upturn
- 5 weeks ago - Zydus Lifesciences completes merger with Assero Holdings for USD 166.33 million - Business Upturn
- 5 weeks ago - Zydus completes acquisition of Assertio Holdings for $23.50 per share - Business Upturn